SCHEMBL31489335

SCHEMBL31489335

Nc1nc2cc(-c3nccc(-c4cnn(C(CC(F)(F)F)c5ccc(F)cc5)c4)n3)ccn2n1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 9/20 0.36
PIK3CD O00329 8/20 0.36
HSP90AA1 P07900 1/20 0.31
RIPK1 Q13546 1/20 0.31
MKNK1 Q9BUB5 1/20 0.31
PIK3CA P42336 2/20 0.31
JAK1 P23458 4/20 0.31
PAK4 O96013 1/20 0.31
PIK3CB P42338 1/20 0.31
CSNK1A1 P48729 1/20 0.31
AAK1 Q2M2I8 1/20 0.31
PIP4K2C Q8TBX8 1/20 0.31
CSNK1G1 Q9HCP0 1/20 0.31
JAK2 O60674 3/20 0.31
TYK2 P29597 3/20 0.31
JAK3 P52333 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489918 0.90 PIK3CG (0.33) PIK3CGPIK3CDRIPK1MKNK1PIK3CA
SCHEMBL31489134 0.89 MEN1 (0.34) PIK3CGPIK3CDRIPK1MKNK1PIK3CA
SCHEMBL31489345 0.87 PIK3CG (0.34) PIK3CGPIK3CDHSP90AA1RIPK1MKNK1
SCHEMBL31489307 0.87 PIK3CG (0.34) PIK3CGPIK3CDHSP90AA1RIPK1MKNK1
SCHEMBL31489375 0.87 MKNK1 (0.31) MKNK1JAK1JAK2TYK2JAK3
SCHEMBL31489599 0.86 PIK3CG (0.38) PIK3CGPIK3CDHSP90AA1RIPK1MKNK1
SCHEMBL31489902 0.85 PIK3CG (0.36) PIK3CGPIK3CDHSP90AA1RIPK1MKNK1
SCHEMBL31489669 0.85 PIK3CG (0.35) PIK3CGPIK3CDHSP90AA1RIPK1MKNK1
SCHEMBL31489445 0.83 PIK3CG (0.35) PIK3CGPIK3CDHSP90AA1RIPK1MKNK1
SCHEMBL31489895 0.82 PIK3CG (0.36) PIK3CGPIK3CDRIPK1PIK3CAJAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 WO disclosed